Bernstein Lowers DaVita's Price Target, Believes Dialysis Biz Is Well Positioned For Long-Term Growth

By: via Benzinga
Bernstein’s Lisa Bedell Clive maintained a Market-Perform rating for DaVita HealthCare Partners Inc (NYSE: DVA), while reducing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.